kol management News

The workshop will look at strategies and tactics for building long-term relationships with opinion leaders taking into account the needs of both the company and the opinion leaders themselves.

Skila, a leading provider of knowledge agility and stakeholder collaboration management solutions, today announced a new and expanded Master Services Agreement (MSA) with Nycomed.

Skila, A Sela2 Company, has recently expanded its active client base by closing nine expansions across five current clients in Q4 of its fiscal year, ending September 30, 2009.

Skila’s iAdvocate Mobile™ solution enhances the iAdvocate™ opinion leader management solution by enabling users to quickly and easily access their iAdvocate™ solution from smart phones.

Bridgewater, N.J., September 14, 2009 – InsiteResearch, LLC, a leading provider of Key Opinion Leader (KOL) relationship management, identification, influence mapping and automated data services to the life sciences industry, is gaining momentum in

Pharma market researchers have cause for concern: Be it from rising state and federal intrusions (e.g., the Physician Payment Sunshine Act) or plain old burnout, fewer healthcare providers (HCPs) are participating in MR than in the past. Peter Gotch,

Skila’s Susan Dorfman, VP Global Marketing, will Chair CBI’s Premier Bio/Pharmaceutical Forum on Integrated Opinion Leader Management Systems being held in King of Prussia, PA.

Skila has announced the release of iAdvocate 2.5, a KOL Management Solution for Medical & Marketing teams in Life Sciences. The solution has been enhanced and the 360° profile has been redesigned to deliver even more relevant and timely information.

Skila continues to build its momentum and global Life Sciences client base by adding five new named clients and six major client expansions across Europe and U.S. in the last quarter.

Skila, A Sela2 Company, announces the release of its next generation Global Key Opinion Leader (KOL) Management Solution, iAdvocate 2.0 – with workflows designed based on the best practices of leading global pharmaceutical organizations.